May 7, 2026
May 7, 2026
May 7, 2026
May 7, 2026
May 7, 2026
May 7, 2026
May 7, 2026
May 6, 2026
Adaptive Biotechnologies' COO sold 57,180 shares at $14.45 per share between April 14-16, 2026. This move might signal strategic shifts or market expectations.